A

Supplementary Appendix S1 from Ribociclib–Letrozole Combination as an Alternative for Neoadjuvant Chemotherapy in Selected Postmenopausal Patients with Luminal Breast Cancer (BOOG 2017-01)

Abstract

Supplementary Appendix S1. Study protocol.

Authors 19

  1. Leiden University Medical Center

    Affiliation as printed

    Department of Medical Oncology , LUMC P.O. Box 9600 , 2300 RC Leiden

  2. Leiden University Medical Center · Borstkanker Onderzoek Groep

    Affiliation as printed

    Department of Surgical Oncology , LUMC Sponsor (in Dutch :

    verrichter/opdrachtgever) BOOG Study Center P.O. Box 9236 , 1006 AE Amsterdam

  3. Leiden University Medical Center · The Netherlands Cancer Institute

    Affiliation as printed

    Department of Medical oncology , LUMC P.O. Box 9600 , 2300 RC Leiden

    medical oncologist , NKI/AvL

Cited by 0 stored of 0

No patents citing this paper on Lens.org (checked 2026-10-11).

References 0